The third quarter featured 21 device M&A transactions, 10 of which had disclosed values that together totaled $7.1bn, versus the second quarter, when 14 deals totaled $2bn. Three transactions cracked the billion dollar mark compared to only one deal meeting this milestone in the second quarter.
Q3’s top device M&A deal was ICU Medical’s definitive agreement to acquire the Smiths Medical division of Smiths Group in a deal valued at up to $2.45bn. Smiths...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?